Trademarks = 3

Forward Citations = 2

Loading Chart...

8 inventors (with patents filed for the assignee):

Lindsay Burns Barbier (4 out of 21 patents)

Michael S Zamloot (4 out of 22 patents)

Shawn Anthony Kucera (3 out of 3 patents)

4. Hoau-Yan Wang (1 out of 20 patents)

5. Stephen William Watt (1 out of 16 patents)

6. Remi Barbier (1 out of 3 patents)

7. Vijay Srirambhatla (1 out of 3 patents)

8. Nadav Friedmann (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12391693 - Solid polymorphs of a FLNA-binding compound and its hydrochloride salts (2025-08-19),

2. 12065440 - Solid polymorphs of a FLNA-binding compound and its hydrochloride salts (2024-08-20),

3. 11661580 - Method of inhibiting tau phosphorylation (2023-05-30),

4. 11370791 - Solid polymorphs of a FLNA-binding compound and its hydrochloride salts (2022-06-28),

5. 11096936 - Cocrystals of naloxone and naltrexone (2021-08-24),

Company Overview

Cassava Sciences is a clinical-stage biotechnology company focused on developing novel treatments for Alzheimer's disease. The company's lead candidate, PTI-125, has shown promising results in early-stage clinical trials in improving cognition and reducing neuroinflammation in Alzheimer's patients. Cassava Sciences aims to bring innovative therapies to market that can improve the lives of individuals affected by neurodegenerative diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#493 in Austin, TX

#3,330 in Texas

#51,570 in US

Austin, TX, United States of America

Cassava Sciences, Inc.

Forward Citations = 2

8 inventors:

Lindsay Burns Barbier (4 out of 21 patents)

Michael S Zamloot (4 out of 22 patents)

Shawn Anthony Kucera (3 out of 3 patents)

4. Hoau-Yan Wang (1 out of 20 patents)

5. Stephen William Watt (1 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cassava Sciences, Inc.. Retrieved from https://idiyas.com/company/cassava-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]